X0202 3 2005-01-03 0 0000849043 NEUROGEN CORP NRGN 0001314394 Chenard Bertrand L 35 NE INDUSTRIAL RD BRANFORD CT 06405 0 1 0 0 VP Chemistry Common Stock 4859 I By 401K Plan Stock Options (Right to Buy) 15.25 2002-09-24 2011-09-24 Common Stock 40000 D Stock Options (Right to Buy) 17.48 2002-12-31 Common Stock 5000 D Stock Options (Right to Buy) 3.87 2003-12-19 Common Stock 25000 D Stock Options (Right to Buy) 8.79 2004-12-15 Common Stock 22500 D Stock Options (Right to Buy) 9.50 2005-05-21 Common Stock 40000 D Stock Options (Right to Buy) 9.05 2005-12-21 Common Stock 24000 D On 9/24/2001 the reporting person was granted an option to purchase 40,000 shares pursuant to the Issuer's Amended and Restated 1993 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 10 years from grant date. On 12/31/2001 the reporting person was granted an option to purchase 5,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. On 12/19/2002 the reporting person was granted an option to purchase 17,500 shares pursuant to the Issuer's Amended and Restated 1993 Neurogen Corporation Stock Option Plan, and granted an option to purchase 7,500 shares pursuant to the issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. On 12/15/2003 the reporting person was granted an option to purchase 22,500 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. On 5/21/2004 the reporting person was granted an option to purchase 40,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. On 12/21/2004 the reporting person was granted an option to purchase 24,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. by Stephen Davis 2005-01-13